# Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease

Study · id `cardio:ct-nct06259019` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06259019](<https://clinicaltrials.gov/study/NCT06259019>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06259019

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT06259019. Allocation not applicable; no masking; primary purpose other. Start 2023-09-14 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT06259019, source copy `cardio:ctgov-nct06259019-2026-04-03`, retrieved 2026-10-26)
- Started: 2023-09-14 (actual) (ClinicalTrials.gov record NCT06259019, source copy `cardio:ctgov-nct06259019-2026-04-03`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT06259019, source copy `cardio:ctgov-nct06259019-2026-04-03`, retrieved 2026-10-26)
- Completion: 2028-02 (anticipated) (ClinicalTrials.gov record NCT06259019, source copy `cardio:ctgov-nct06259019-2026-04-03`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT06259019, source copy `cardio:ctgov-nct06259019-2026-04-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06259019-2026-04-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
- Acronym: BIOPATTERN
- Condition: Coronary Artery Disease
- Intervention (Device): Liquid Biopsy System (LBS)
- Lead sponsor: PlaqueTec Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: Royal Papworth Hospital
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: cb84e35c81d8c2905f922c92d0649017998f374a442de8280c40e50e9b136089
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
